Antimetter Pharmaceuticals Private Limited - Company Profile

It is a chemicals private limited company based in Diva, Maharashtra, India, established in 2020.
2020 Diva, Maharashtra, India Active
Last Updated:
Access Report
About Antimetter Pharmaceuticals Private Limited

Antimetter Pharmaceuticals Private Limited, a active private limited company, was established on 28 December 2020 in Diva, Maharashtra, India. Engaging in manufacturing within the chemicals sector, it holds CIN: U24290MH2020PTC352618. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Satya Narayan (Director), Prafulla Eknath Shinde (Director), Binjay Jayshankar Dubey (Director). It is based at Sidhivinayak Garden Building No B1 Fifth Floor Flat No 505, Near Prerana Tower,, Diva, Maharashtra, 400612.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24290MH2020PTC352618

  • Registration Number

    352618

  • Incorporation Date

    28 December 2020

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 5 Year, 1 Month
Company report

Antimetter Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Antimetter Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Antimetter Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Satya Narayan Director 28 Dec 2020 Current
Prafulla Eknath Shinde Director 28 Dec 2020 Current
Binjay Jayshankar Dubey Director 28 Dec 2020 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Antimetter Pharmaceuticals.

Enhance accessibility to Antimetter Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Antimetter Pharmaceuticals revenue growth over time
Antimetter Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Antimetter Pharmaceuticals?

Unlock access to Antimetter Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Antimetter Pharmaceuticals?

Antimetter Pharmaceuticals has a workforce of 0 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Antimetter Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Antimetter Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Antimetter Pharmaceuticals
Recent Activity within the Organization
  • Director Appointment

    Progress on Satya Narayan was appointed as a Director was appointed as a Director on 28 Dec 2020 & has been associated with this company since 5 years 1 month . was documented.

  • Director Appointment

    Prafulla Eknath Shinde was appointed as a Director was appointed as a Director on 28 Dec 2020 & has been associated with this company since 5 years 1 month . was recorded as a recent event.

  • Director Appointment

    Progress on Binjay Jayshankar Dubey was appointed as a Director was appointed as a Director on 28 Dec 2020 & has been associated with this company since 5 years 1 month . was documented.

  • Company Incorporation

    Progress on Antimetter Pharmaceuticals Private Limited was registered on 28 Dec 2020 with Roc Mumbai & aged 5 years 1 month as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Antimetter Pharmaceuticals Private Limited?

The CIN of Antimetter Pharmaceuticals Private Limited is U24290MH2020PTC352618.

Where is Antimetter Pharmaceuticals Private Limited headquartered?

Antimetter Pharmaceuticals Private Limited is headquartered at Sidhivinayak Garden Building No B1 Fifth Floor Flat No 505, Near Prerana Tower,, Diva, Maharashtra, 400612.

When was Antimetter Pharmaceuticals Private Limited incorporated?

Antimetter Pharmaceuticals Private Limited was incorporated on 28 December 2020.

Who are the current directors of Antimetter Pharmaceuticals Private Limited?

The current directors of Antimetter Pharmaceuticals Private Limited are

What is the primary industry of Antimetter Pharmaceuticals Private Limited?

The primary industry of Antimetter Pharmaceuticals Private Limited is Chemicals.

Is Antimetter Pharmaceuticals Private Limited a listed company?

Antimetter Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Antimetter Pharmaceuticals Private Limited?

The authorized capital of Antimetter Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available